$18.57
0.02[0.11%]
Last update: 8:30AM Get Real Time Here
Kiniksa Pharmaceuticals
(NASDAQ:KNSA)Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Insider Trading Activity
Kiniksa Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
70.940M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Sanj Patel | CHAIRMAN & CEO | -65.012K | $21.02 | -$1.37M | SELL | -55.32% | 52.516K | Mar 07 | View |
| Mar 06, 2024 | Sanj Patel | CHAIRMAN & CEO | -18.324K | $21.34 | -$391.06K | SELL | -13.49% | 117.528K | Mar 04 - Mar 06 | View |
| Mar 05, 2024 | Eben Tessari | CHIEF OPERATING OFFICER | -533 | $11.81 | -$25.15K | SELL | -0.43% | 122.847K | Mar 01 | View |
| Mar 05, 2024 | John Paolini | CHIEF MEDICAL OFFICER | 0 | $11.81 | -$375.18K | SELL-OPTIONS | 0.00% | 44.892K | Mar 01 | View |
| Mar 01, 2024 | Michael Megna | CHIEF ACCOUNTING OFFICER | 583 | $15.93 | -$160.86K | SELL-OPTIONS | 3.43% | 17.588K | Jan 15 - Mar 01 | View |
| Feb 29, 2024 | John Paolini | CHIEF MEDICAL OFFICER | 0 | $11.45 | -$194.69K | SELL-OPTIONS | 0.00% | 44.892K | Feb 27 | View |
| Jan 04, 2024 | Mark Ragosa | CHIEF FINANCIAL OFFICER | 0 | $14.41 | -$134.04K | SELL-OPTIONS | 0.00% | 15.632K | Jan 03 | View |
| Jan 04, 2024 | Michael Megna | CHIEF ACCOUNTING OFFICER | 0 | $16.53 | -$88.18K | SELL-OPTIONS | 0.00% | 17.005K | Jan 02 | View |
| Dec 21, 2023 | Michael Megna | CHIEF ACCOUNTING OFFICER | 0 | $16.50 | -$48.91K | SELL-OPTIONS | 0.00% | 17.005K | Dec 19 | View |
| Dec 11, 2023 | John Paolini | CHIEF MEDICAL OFFICER | 0 | $9.75 | -$451.56K | SELL-OPTIONS | 0.00% | 44.892K | Dec 07 | View |
| Sep 06, 2023 | John Paolini | CHIEF MEDICAL OFFICER | 2.982K | $9.78 | -$28.31K | SELL-OPTIONS | 7.12% | 44.892K | Sep 01 - Sep 05 | View |
| Jul 27, 2023 | John Paolini | CHIEF MEDICAL OFFICER | 0 | $10.50 | -$501.22K | SELL-OPTIONS | 0.00% | 41.91K | Jul 25 | View |
| Dec 01, 2022 | Barry Quart | 0 | $8.87 | -$319.72K | SELL-OPTIONS | 0.00% | 0 | Nov 29 | View | |
| Nov 09, 2022 | John Paolini | CHIEF MEDICAL OFFICER | 0 | $8.52 | -$377.72K | SELL-OPTIONS | 0.00% | 36.335K | Nov 07 | View |
| Feb 10, 2021 | Sanj K Patel | CHAIRMAN & CEO | -29.234K | $12.32 | -$1.25M | SELL | -13.15% | 193.131K | Feb 08 - Feb 10 | View |
| Feb 05, 2021 | Thomas W Beetham | EVP & CHIEF LEGAL OFFICER | 297.523K | $22.09 | -$54.72K | SELL-OPTIONS | ∞ | 297.523K | Feb 03 | View |
| Oct 14, 2020 | Sanj K Patel | -100K | $11.30 | -$5.05M | OPTION EXERCISE | -31.02% | 222.365K | Oct 09 - Oct 12 | View | |
| Jul 02, 2020 | Thomas W Beetham | -29.589K | $25.37 | -$750.68K | SELL | -100.00% | 0 | Jul 01 | View | |
| Jun 12, 2020 | Thomas W Beetham | 0 | $13.33 | -$322.90K | OPTION EXERCISE | 0.00% | 29.589K | Jun 10 | View | |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.